TKO Group Holdings walks into Thursday's Q1 results carrying a fresh bellwether endorsement — and short sellers who have yet to be shaken out.
Morgan Stanley upgraded the stock to Overweight last week, lifting its target to $225 from $215. The move is notable because it arrives just as TKO has bounced 3.7% over the past week to $190.47, recovering from a rough month that saw the stock fall 6.5%. The analyst consensus target now sits at roughly $235, implying over 25% upside from current levels — and the analyst recommendation score ranks in the 95th percentile of the ORTEX universe, a signal that the Street is broadly constructive. Bernstein trimmed its target to $240 from $250 while holding its Outperform rating, a modest step back rather than a directional shift.
The short side, however, is not capitulating. Short interest has eased 9% over the past month but still accounts for 11.6% of the free float — a meaningfully elevated position. The ORTEX short score of 65.8 reflects sustained bearish conviction rather than a fresh pile-on. Crucially, the lending market shows no sign of squeeze pressure: borrow costs are low at just 0.48% APR and have drifted lower over the past month. Availability remains comfortable, which means new shorts can be added without friction — the borrow market is not working against them. Bears will likely focus on what the bull case itself acknowledges as a risk: 2026 revenue guidance that leans on events where some lack meaningful revenue contribution, as well as rising fighter pay pressures and the uncertainty around new rights deals.
Options traders flipped sharply bullish ahead of this print. The put/call ratio has collapsed from above 2.3 in early April — when tariff anxiety briefly drove defensive positioning to near-52-week highs — to just 0.63 today, well below its 20-day average of 0.95. That's a dramatic reversal in sentiment. Call demand is running hot relative to recent norms, a contrast to the pessimism visible in the short book. The single confirmed historical data point backs caution about reading too much into options sentiment: after TKO's February 2026 Q4 print, the stock jumped 8% on day one but gave back most of the gain over the following week, settling just 2.2% higher.
Bulls point to TKO's structural advantages — captive fan bases for UFC and WWE, premium-priced media rights, and a credible path to $1 billion in partnership revenue by 2030. Free cash flow generation has been strong enough to support buybacks and a growing dividend, with the forward yield scoring in the 79th percentile on ORTEX's dividend score. State Street more than doubled its position in Q1, adding over 2 million shares, and MFS built its stake by over 1.1 million — institutional accumulation that aligns with the bullish analyst direction.
The print is therefore less about whether TKO can grow and more about whether management's 2026 revenue guidance holds up against a calendar that includes events the bears have flagged as low-revenue fillers — and whether margin discipline is intact as international expansion and fighter compensation costs climb.
See the live data behind this article on ORTEX.
Open TKO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
